The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
Saved in:
| Title: | The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease. |
|---|---|
| Authors: | Younossi, Zobair M.1,2,3 (AUTHOR) zobair.younossi@inova.org, Stepanova, Maria1,2,3,4 (AUTHOR), Felix, Sean1,2,3 (AUTHOR), Jeffers, Thomas1,2,3 (AUTHOR), Younossi, Elena1,2,3 (AUTHOR), Goodman, Zachary1,2,3 (AUTHOR), Racila, Andrei1,2,3 (AUTHOR), Lam, Brian P.1,2,3 (AUTHOR), Henry, Linda1,2,3,4 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Jun2023, Vol. 57 Issue 12, p1417-1422. 6p. 2 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.17472 |
